These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36008402)

  • 21. Significance of achaete-scute complex homologue 1 (ASCL1) in pulmonary neuroendocrine carcinomas; RNA sequence analyses using small cell lung cancer cells and Ascl1-induced pulmonary neuroendocrine carcinoma cells.
    Kudoh S; Tenjin Y; Kameyama H; Ichimura T; Yamada T; Matsuo A; Kudo N; Sato Y; Ito T
    Histochem Cell Biol; 2020 Jun; 153(6):443-456. PubMed ID: 32170367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC.
    Mohammad HP; Smitheman KN; Kamat CD; Soong D; Federowicz KE; Van Aller GS; Schneck JL; Carson JD; Liu Y; Butticello M; Bonnette WG; Gorman SA; Degenhardt Y; Bai Y; McCabe MT; Pappalardi MB; Kasparec J; Tian X; McNulty KC; Rouse M; McDevitt P; Ho T; Crouthamel M; Hart TK; Concha NO; McHugh CF; Miller WH; Dhanak D; Tummino PJ; Carpenter CL; Johnson NW; Hann CL; Kruger RG
    Cancer Cell; 2015 Jul; 28(1):57-69. PubMed ID: 26175415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA-Binding Protein
    Loh XY; Sun QY; Ding LW; Mayakonda A; Venkatachalam N; Yeo MS; Silva TC; Xiao JF; Doan NB; Said JW; Ran XB; Zhou SQ; Dakle P; Shyamsunder P; Koh AP; Huang RY; Berman BP; Tan SY; Yang H; Lin DC; Koeffler HP
    Cancer Res; 2020 Jan; 80(2):219-233. PubMed ID: 31551365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ZFP36L1 negatively regulates erythroid differentiation of CD34+ hematopoietic stem cells by interfering with the Stat5b pathway.
    Vignudelli T; Selmi T; Martello A; Parenti S; Grande A; Gemelli C; Zanocco-Marani T; Ferrari S
    Mol Biol Cell; 2010 Oct; 21(19):3340-51. PubMed ID: 20702587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LSD1 modulates the non-canonical integrin β3 signaling pathway in non-small cell lung carcinoma cells.
    Lim SY; Macheleidt I; Dalvi P; Schäfer SC; Kerick M; Ozretić L; Ortiz-Cuaran S; George J; Merkelbach-Bruse S; Wolf J; Timmermann B; Thomas RK; Schweiger MR; Buettner R; Odenthal M
    Sci Rep; 2017 Aug; 7(1):10292. PubMed ID: 28860622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The malignant brain tumor (MBT) domain protein SFMBT1 is an integral histone reader subunit of the LSD1 demethylase complex for chromatin association and epithelial-to-mesenchymal transition.
    Tang M; Shen H; Jin Y; Lin T; Cai Q; Pinard MA; Biswas S; Tran Q; Li G; Shenoy AK; Tongdee E; Lin S; Gu Y; Law BK; Zhou L; Mckenna R; Wu L; Lu J
    J Biol Chem; 2013 Sep; 288(38):27680-27691. PubMed ID: 23928305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ARE-binding protein ZFP36L1 interacts with CNOT1 to directly repress translation via a deadenylation-independent mechanism.
    Otsuka H; Fukao A; Tomohiro T; Adachi S; Suzuki T; Takahashi A; Funakami Y; Natsume T; Yamamoto T; Duncan KE; Fujiwara T
    Biochimie; 2020 Jul; 174():49-56. PubMed ID: 32311426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of secretagogin as a marker for the diagnosis of lung neuroendocrine carcinoma.
    Baykara Y; Xiao Y; Yang D; Yakirevich E; Maleki S; Garcia-Moliner M; Wang LJ; Huang CK; Lu S
    Virchows Arch; 2022 Jul; 481(1):31-39. PubMed ID: 35357570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ZFP36L1 negatively regulates plasmacytoid differentiation of BCL1 cells by targeting BLIMP1 mRNA.
    Nasir A; Norton JD; Baou M; Zekavati A; Bijlmakers MJ; Thompson S; Murphy JJ
    PLoS One; 2012; 7(12):e52187. PubMed ID: 23284928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LSD1 Inhibition Promotes Epithelial Differentiation through Derepression of Fate-Determining Transcription Factors.
    Egolf S; Aubert Y; Doepner M; Anderson A; Maldonado-Lopez A; Pacella G; Lee J; Ko EK; Zou J; Lan Y; Simpson CL; Ridky T; Capell BC
    Cell Rep; 2019 Aug; 28(8):1981-1992.e7. PubMed ID: 31433976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Class III/IV POU transcription factors expressed in small cell lung cancer cells are involved in proneural/neuroendocrine differentiation.
    Ishii J; Sato H; Yazawa T; Shishido-Hara Y; Hiramatsu C; Nakatani Y; Kamma H
    Pathol Int; 2014 Sep; 64(9):415-22. PubMed ID: 25243889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KDM6A epigenetically regulates subtype plasticity in small cell lung cancer.
    Duplaquet L; Li Y; Booker MA; Xie Y; Olsen SN; Patel RA; Hong D; Hatton C; Denize T; Walton E; Laimon YN; Li R; Jiang Y; Bronson RT; Southard J; Li S; Signoretti S; Qiu X; Cejas P; Armstrong SA; Long HW; Tolstorukov MY; Haffner MC; Oser MG
    Nat Cell Biol; 2023 Sep; 25(9):1346-1358. PubMed ID: 37591951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRISPR-suppressor scanning reveals a nonenzymatic role of LSD1 in AML.
    Vinyard ME; Su C; Siegenfeld AP; Waterbury AL; Freedy AM; Gosavi PM; Park Y; Kwan EE; Senzer BD; Doench JG; Bauer DE; Pinello L; Liau BB
    Nat Chem Biol; 2019 May; 15(5):529-539. PubMed ID: 30992567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulinoma-associated protein 1 is a sensitive and specific marker of neuroendocrine lung neoplasms in cytology specimens.
    Doxtader EE; Mukhopadhyay S
    Cancer Cytopathol; 2018 Apr; 126(4):243-252. PubMed ID: 29360191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zinc Finger Protein ZFP36L1 Inhibits Flavivirus Infection by both 5'-3' XRN1 and 3'-5' RNA-Exosome RNA Decay Pathways.
    Chiu H; Chiu HP; Yu HP; Lin LH; Chen ZP; Lin YL; Lin RJ
    J Virol; 2022 Jan; 96(1):e0166521. PubMed ID: 34643435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic Regulators Open the Door to SCLC Plasticity.
    Weber MC; Izzo LT; Oliver TG
    Cancer Res; 2023 Nov; 83(21):3495-3497. PubMed ID: 37756567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sonic hedgehog signaling pathway promotes INSM1 transcription factor in neuroendocrine lung cancer.
    Chen C; Breslin MB; Lan MS
    Cell Signal; 2018 Jun; 46():83-91. PubMed ID: 29501727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LSD1/KDM1A inhibitors in clinical trials: advances and prospects.
    Fang Y; Liao G; Yu B
    J Hematol Oncol; 2019 Dec; 12(1):129. PubMed ID: 31801559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncogene LSD1 is epigenetically suppressed by miR-137 overexpression in human non-small cell lung cancer.
    Zhang X; Zhang X; Yu B; Hu R; Hao L
    Biochimie; 2017 Jun; 137():12-19. PubMed ID: 28223039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel LSD1 Inhibitor T-3775440 Disrupts GFI1B-Containing Complex Leading to Transdifferentiation and Impaired Growth of AML Cells.
    Ishikawa Y; Gamo K; Yabuki M; Takagi S; Toyoshima K; Nakayama K; Nakayama A; Morimoto M; Miyashita H; Dairiki R; Hikichi Y; Tomita N; Tomita D; Imamura S; Iwatani M; Kamada Y; Matsumoto S; Hara R; Nomura T; Tsuchida K; Nakamura K
    Mol Cancer Ther; 2017 Feb; 16(2):273-284. PubMed ID: 27903753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.